Guest guest Posted December 17, 2004 Report Posted December 17, 2004 Class II Special Controls Guidance Document: Implantable Radiofrequency Transponder System for Patient Identification and Health Information, " FDA Classifies Implantable Chip Mobile Health Data December 10, 2004 The Food and Drug Administration has published a final rule classifying the VeriChip implantable radio frequency identification system as a Class II medical device with special controls. The special controls that will apply to the device -- which the FDA recently approved for marketing -- are explained in a guidance document the agency also has published. The FDA on Dec. 10 published in the Federal Register the final rule and a notice about the guidance document, available at www.gpoaccess.gov/fr/index.html. Text of the guidance, document number 1541 and titled, " Class II Special Controls Guidance Document: Implantable Radiofrequency Transponder System for Patient Identification and Health Information, " is available at www.fda.gov/cdrh. The grain-sized VeriChip from Delray Beach, Fla.-based Applied Digital is designed to enable physicians to have electronic access via the Internet to specific patient information, such as allergies or medical history. The chip, inserted under the skin on the right arm, contains a 16-digit identification number that is captured by passing a proprietary scanner over the insertion site. The identification number links to a database containing the patient's medical information. The technology already is used in several non-medical procedures, such as identifying pets and livestock, and granting physical access to secure areas, according to the vendor. For more information, visit www.adsx.com. http://www.mobilehealthdata.com/article.cfm?articleid=1173 Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.